Climb Bio, Inc. (CLYM) Tops Q2 EPS by 5c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q2 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance